{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:05:07Z","timestamp":1791831907268,"version":"4.3.4"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.carrev.2020.11.023","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T10:02:10Z","timestamp":1605866530000},"page":"63-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Real-World Experience of the MANTA Closure Device: Insights From the FDA Manufacturer and User Facility Device Experience (MAUDE) Database"],"prefix":"10.1016","volume":"27","author":[{"given":"Brian C.","family":"Case","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charan","family":"Yerasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Forrestal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sant","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anees","family":"Musallam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chava","family":"Chezar-Azerrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nauman","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Shlofmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaffar M.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lowell F.","family":"Satler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itsik","family":"Ben-Dor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Waksman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2020.11.023_bb0005","first-page":"1200","article-title":"Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis","volume":"44","author":"Nikolsky","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2020.11.023_bb0010","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jvs.2009.01.062","article-title":"Patches for carotid artery endarterectomy: current materials and prospects","volume":"50","author":"Muto","year":"2009","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.carrev.2020.11.023_bb0015","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.amjcard.2012.06.042","article-title":"Incidence, predictors, and implications of access site complications with transfemoral transcatheter aortic valve implantation","volume":"110","author":"Van Mieghem","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2020.11.023_bb0020","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jacc.2012.07.003","article-title":"Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (placement of AoRTic TraNscathetER valve) trial","volume":"60","author":"Genereux","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2020.11.023_bb0025","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.jcin.2016.03.010","article-title":"The MANTA vascular closure device: a novel device for large-bore vessel closure","volume":"9","author":"van Gils","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.11.023_bb0030","doi-asserted-by":"crossref","first-page":"896","DOI":"10.4244\/EIJV12I7A147","article-title":"MANTA, a novel plug-based vascular closure device for large bore arteriotomies: technical report","volume":"12","author":"van Gils","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2020.11.023_bb0035","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.007258","article-title":"Pivotal clinical study to evaluate the safety and effectiveness of the MANTA percutaneous vascular closure device","volume":"12","author":"Wood","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.11.023_bb0040","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jcin.2016.12.277","article-title":"Percutaneous plug-based arteriotomy closure device for large-bore access: a multicenter prospective study","volume":"10","author":"Van Mieghem","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.11.023_bb0045","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.carrev.2020.03.032","article-title":"Safety and effectiveness of MANTA vascular closure device after large-bore mechanical circulatory support: real-world experience","volume":"21","author":"Gupta","year":"2020","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2020.11.023_bb0050","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.carrev.2020.04.003","article-title":"Review of CRT 2020 late-breaking trials","volume":"21","author":"Yerasi","year":"2020","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2020.11.023_bb0055","first-page":"954","article-title":"Impact of percutaneous femoral arteriotomy closure using the MANTA(TM) device on vascular and bleeding complications after transcatheter aortic valve replacement","volume":"92","author":"De Palma","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.11.023_bb0060","first-page":"998","article-title":"Percutaneous axillary arteriotomy closure during transcatheter aortic valve replacement using the MANTA device","volume":"92","author":"De Palma","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.11.023_bb0065","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.carrev.2019.11.014","article-title":"Real-world experience of the sentinel cerebral protection device: insights from the FDA manufacturer and user facility device experience (MAUDE) database","volume":"21","author":"Case","year":"2020","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2020.11.023_bb0070","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.carrev.2019.03.009","article-title":"Techniques to optimize the use of optical coherence tomography: insights from the manufacturer and user facility device experience (MAUDE) database","volume":"20","author":"Shlofmitz","year":"2019","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2020.11.023_bb0075","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.carrev.2019.02.016","article-title":"Adverse events associated with the use of guide extension catheters during percutaneous coronary intervention: reports from the manufacturer and user facility device experience (MAUDE) database","volume":"20","author":"Chen","year":"2019","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2020.11.023_bb0080","first-page":"157","article-title":"Adverse events and modes of failure related to the FilterWire EZ embolic protection system: lessons learned from an analytic review of the FDA MAUDE database","volume":"94","author":"Khalid","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.11.023_bb0085","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.4244\/EIJ-D-19-00295","article-title":"Adverse events with orbital atherectomy: an analytic review of the MAUDE database","volume":"16","author":"Khalid","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2020.11.023_bb0090","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.jcin.2019.06.049","article-title":"Insights from a multidisciplinary introduction of the MANTA vascular closure device","volume":"12","author":"Moccetti","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.11.023_bb0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijcard.2018.04.065","article-title":"MANTA versus ProGlide vascular closure devices in transfemoral transcatheter aortic valve implantation","volume":"263","author":"Biancari","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2020.11.023_bb0100","doi-asserted-by":"crossref","first-page":"e1558","DOI":"10.4244\/EIJ-D-18-00769","article-title":"Propensity-matched comparison of vascular closure devices after transcatheter aortic valve replacement using MANTA versus ProGlide","volume":"14","author":"Moriyama","year":"2019","journal-title":"EuroIntervention"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838920307739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838920307739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:20:35Z","timestamp":1761560435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838920307739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":20,"alternative-id":["S1553838920307739"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2020.11.023","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-World Experience of the MANTA Closure Device: Insights From the FDA Manufacturer and User Facility Device Experience (MAUDE) Database","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2020.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}